Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Landos Biopharma, Inc. | Chief Medical Officer | Restricted Stock Unit | 0 | $0 | $0.69 | May 23, 2024 | Direct |
Landos Biopharma, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 0 | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LABP | Landos Biopharma, Inc. | May 23, 2024 | 3 | $0 | 4 | May 23, 2024 | Chief Medical Officer |
LABP | Landos Biopharma, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Medical Officer |
LABP | Landos Biopharma, Inc. | Feb 28, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Chief Medical Officer |
LABP | Landos Biopharma, Inc. | Sep 5, 2022 | 1 | $0 | 4 | Sep 7, 2022 | Chief Medical Officer |
LABP | Landos Biopharma, Inc. | Sep 5, 2022 | 0 | $0 | 3 | Sep 7, 2022 | Chief Medical Officer |